Viewing Study NCT04961632


Ignite Creation Date: 2025-12-24 @ 9:46 PM
Ignite Modification Date: 2025-12-26 @ 2:13 PM
Study NCT ID: NCT04961632
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-01
First Post: 2021-07-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
Sponsor: National Cancer Centre, Singapore
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module